Fundraising FoxPyramid Biosciences
Waltham, US · Founded 2015 · Delaware corporation · 1 known investors
Find your way into Pyramid Biosciences
Sign up to find every way you can get introduced to Pyramid Biosciences
- Your email: who you already know at Pyramid Biosciences, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Pyramid Biosciences team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
Investors · 1
Reported raises · per SEC filings
Form D private placements$52M disclosed across 5 rounds · 2016–2021
▶$33.5MraisedOct 2021 · 56 investors · BiotechnologyRule 506(b)
▶$33.5MraisedOct 2021 · 56 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Larry FeinbergDirector
- Vladimir CoricDirector
- Jordan LeefExecutive Officer, Director
- John ChildsDirector
- Kollol PalExecutive Officer, Director
- Amount sold
- $33.5M
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8.8MraisedAug 2020 · 48 investors · BiotechnologyRule 506(b)
▶$8.8MraisedAug 2020 · 48 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- John ChildsDirector
- Vladimir CoricDirector
- Kollol PalExecutive Officer, Director
- Jordan LeefExecutive Officer, Director
- Offering amount
- $18M
- Amount sold
- $8.8M
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$3.6MraisedJul 2020 · 50 investors · BiotechnologyRule 506(b)
▶$3.6MraisedJul 2020 · 50 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jordan LeefExecutive Officer, Director
- Kollol PalExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $3.6M
- First sale
- Nov 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$6MraisedJul 2020 · 103 investors · BiotechnologyRule 506(b)
▶$6MraisedJul 2020 · 103 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kollol PalExecutive Officer, Director
- Jordan LeefExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $6M
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$17.3KraisedAug 2018 · 1 investors · BiotechnologyRule 506(b)
▶$17.3KraisedAug 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kollol PalExecutive Officer, Director
- Offering amount
- $17.3K
- Amount sold
- $17.3K
- First sale
- Jul 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Pyramid Biosciences's investors?
- Pyramid Biosciences's investors include Boston Harbor Angels.
- How much funding has Pyramid Biosciences raised?
- Pyramid Biosciences has disclosed $52M raised across 5 rounds.
- Where is Pyramid Biosciences headquartered?
- Pyramid Biosciences is headquartered in Waltham, US.